Skip to content

VANDA PHARMACEUTICALS INC.: filings

Every VANDA PHARMACEUTICALS INC. annual and quarterly report in the SEC record with the published financial measures it tagged, 61 filings, each linked to its SEC index.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-Q2026-08-06fiscal Q2 2026401170001628280-26-053855
10-Q2026-05-07fiscal Q1 202640850001628280-26-031667
10-K2026-02-12fiscal FY 2025461200001628280-26-007460
10-Q2025-10-30fiscal Q3 2025401210001628280-25-047317
10-Q2025-07-31fiscal Q2 2025401170001628280-25-036861
10-Q2025-05-08fiscal Q1 202540850001628280-25-023448
10-K2025-02-14fiscal FY 2024461200001628280-25-005761
10-Q2024-11-07fiscal Q3 2024391190001628280-24-045970
10-Q2024-08-01fiscal Q2 2024391150001628280-24-033866
10-Q2024-05-09fiscal Q1 202439830001628280-24-021952
10-K2024-02-08fiscal FY 2023461210001628280-24-003785
10-Q2023-11-09fiscal Q3 2023401210001628280-23-038029
10-Q2023-07-28fiscal Q2 2023401170001628280-23-026000
10-Q2023-05-03fiscal Q1 202339830001628280-23-015267
10-K2023-02-09fiscal FY 2022451180001628280-23-002857
10-Q2022-11-03fiscal Q3 2022401210001628280-22-027951
10-Q2022-08-04fiscal Q2 2022401170001628280-22-020848
10-Q2022-05-06fiscal Q1 202240850001628280-22-012834
10-K2022-02-24fiscal FY 2021451180001628280-22-003629
10-Q2021-11-04fiscal Q3 2021401210001347178-21-000032
10-Q2021-07-29fiscal Q2 2021391130001347178-21-000028
10-Q2021-05-06fiscal Q1 202139830001347178-21-000015
10-K2021-02-11fiscal FY 2020461650001347178-21-000005
10-Q2020-10-29fiscal Q3 2020391170001347178-20-000030
10-Q2020-08-06fiscal Q2 2020391130001347178-20-000024
10-Q2020-05-07fiscal Q1 202039830001347178-20-000013
10-K2020-02-26fiscal FY 2019461620001347178-20-000003
10-Q2019-11-07fiscal Q3 2019421210001347178-19-000017
10-Q2019-08-01fiscal Q2 2019381090001347178-19-000014
10-Q2019-05-03fiscal Q1 201938790001347178-19-000011
10-K2019-02-19fiscal FY 2018381370001347178-19-000003
10-Q2018-11-07fiscal Q3 201834940001347178-18-000010
10-Q2018-08-02fiscal Q2 201834940001347178-18-000007
10-Q2018-05-02fiscal Q1 201834690001193125-18-148848
10-K2018-02-15fiscal FY 2017351200001193125-18-046425
10-Q2017-11-08fiscal Q3 201728720001193125-17-336447
10-Q2017-08-03fiscal Q2 201728720001193125-17-246701
10-Q2017-05-03fiscal Q1 201728560001193125-17-154971
10-K2017-02-17fiscal FY 2016371240001193125-17-047317
10-Q2016-11-03fiscal Q3 201628740001193125-16-757991
10-Q2016-07-28fiscal Q2 201628740001193125-16-661038
10-Q2016-05-05fiscal Q1 201628570001193125-16-578637
10-K2016-02-12fiscal FY 2015361320001193125-16-461076
10-Q2015-11-04fiscal Q3 201527700001193125-15-365182
10-Q2015-07-31fiscal Q2 201530760001193125-15-271844
10-Q2015-05-07fiscal Q1 201530620001193125-15-177216
10-K2015-03-13fiscal FY 2014381260001193125-15-091300
10-Q2014-10-27fiscal Q3 201431740001193125-14-382267
10-Q2014-08-08fiscal Q2 201430750001193125-14-301702
10-Q2014-05-08fiscal Q1 201432640001193125-14-188616
10-K2014-02-25fiscal FY 2013391390001193125-14-066051
10-Q2013-11-08fiscal Q3 201335910001193125-13-433952
10-Q2013-07-31fiscal Q2 201334910001193125-13-311423
10-Q2013-05-10fiscal Q1 201335700001193125-13-212435
10-K2013-02-26fiscal FY 2012411320001193125-13-075214
10-Q2012-11-08fiscal Q3 2012401000001193125-12-458846
10-Q2012-08-03fiscal Q2 201237930001193125-12-333283
10-Q2012-05-09fiscal Q1 201233660001193125-12-220200
10-K2012-03-09fiscal FY 201136920001193125-12-105284
10-Q2011-11-07fiscal Q3 201136900001193125-11-298600
10-Q2011-08-05fiscal Q2 201135870000950123-11-073247

Inspect the source

Entity
VANDA PHARMACEUTICALS INC. / CIK 0001347178
Captured
2026-09-20T07:54:54.067Z
SEC response SHA-256
73fc153c337a0fde6ea6f321d6378d9f94925087244e6f7cab0e2262e4e90436

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001347178.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))